Pfizer tops 2Q profit forecasts


The New York company had profit of 51 cents per share. Earnings, adjusted for one-time gains and costs, came to 67 cents per share, beating Wall Street expectations by 2 cents, according to a survey by Zacks Investment Research.



from Biotech News